Video | 15 February 2020 A recipe for an affordable medicine goes bad 1 min RESEARCH AND DEVELOPMENT Governments use taxpayer money to try to get Big Pharma to develop medicines we need. These incentives are supposed to be the ingredients for an affordable medicine. Watch the video to see how it really turns out. Share this message! Tell your leaders: We won’t pay twice for medicines any more. Share on Read, watch, share Filter by - Any -BlogEventsFeature storyInfographicIssue briefLetterNewsletterOpinion articlePress releaseReportResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Peter Bauza Opinion article Opinion article | 09 May 2019 Intellectual property and trade Research and development Europe Medicines shouldn’t be a luxury: it’s time to stop big pharma’s profiteering 4 min Opinion article Opinion article | 07 March 2019 Research and development Norway Norway has invested 200 million euros in epidemic preparedness, but are they getting what they’re paying for? 5 min Letter Letter | 05 March 2019 Research and development Open letter to CEPI Board Members: Revise CEPI's access policy Oksana Parafeniuk Feature story Feature story Hepatitis C HIV/AIDS Research and development Tuberculosis Vaccines Then & Now in Access to Medicines: Changes & Challenges 4 min Statement | 29 January 2019 Research and development 144th WHO EB: Medicines, vaccines and health products - Access to medicines and vaccines 2 min Statement | 29 January 2019 Research and development 144th WHO EB: Medicines, vaccines and health products: Cancer medicines 2 min Photograph by Todd Brown Press release Press release | 14 May 2018 Research and development MSF responds to President Trump's speech on drug pricing 3 min Statement | 13 March 2018 Research and development FP9 Public Consultation on EU funds in the area of investment, research & innovation, SME's and single market 9 min Load More
Peter Bauza Opinion article Opinion article | 09 May 2019 Intellectual property and trade Research and development Europe Medicines shouldn’t be a luxury: it’s time to stop big pharma’s profiteering 4 min
Opinion article Opinion article | 07 March 2019 Research and development Norway Norway has invested 200 million euros in epidemic preparedness, but are they getting what they’re paying for? 5 min
Letter Letter | 05 March 2019 Research and development Open letter to CEPI Board Members: Revise CEPI's access policy
Oksana Parafeniuk Feature story Feature story Hepatitis C HIV/AIDS Research and development Tuberculosis Vaccines Then & Now in Access to Medicines: Changes & Challenges 4 min
Statement | 29 January 2019 Research and development 144th WHO EB: Medicines, vaccines and health products - Access to medicines and vaccines 2 min
Statement | 29 January 2019 Research and development 144th WHO EB: Medicines, vaccines and health products: Cancer medicines 2 min
Photograph by Todd Brown Press release Press release | 14 May 2018 Research and development MSF responds to President Trump's speech on drug pricing 3 min
Statement | 13 March 2018 Research and development FP9 Public Consultation on EU funds in the area of investment, research & innovation, SME's and single market 9 min
